TRIB3通过与E2F1相互作用并增强PKM2介导的肿瘤糖酵解促进子宫内膜癌进展
本研究探索TRIB3在子宫内膜癌中的作用及机制。单细胞RNA测序和TCGA数据检测TRIB3表达,免疫组化、qRT-PCR和western blot检测人子宫内膜癌与癌旁非肿瘤组织中TRIB3表达,体外体内验证其致癌功能并研究TRIB3、E2F1与PKM2的相互作用。结果示TRIB3在子宫内膜癌组织中上调且高表达与患者生存差相关,TRIB3与E2F1相互作用抑制其降解,稳定表达的E2F1作为PKM2转录因子增强其表达,TRIB3通过稳定E2F1和增强PKM2转录促进子宫内膜癌细胞恶性行为和糖酵解;异种移植小鼠模型中沉默TRIB3抑制子宫内膜癌生长和糖酵解;吲达帕胺被鉴定为TRIB3的化合物抑制剂,在体外抑制子宫内膜癌生长。
要点
- TRIB3在子宫内膜癌组织中上调,高表达与患者生存差相关。
- TRIB3通过稳定E2F1并增强PKM2转录促进子宫内膜癌细胞恶性行为和糖酵解。
- 异种移植小鼠模型中沉默TRIB3抑制子宫内膜癌生长和糖酵解。
核心结论
- TRIB3可通过与E2F1相互作用并增强PKM2介导的肿瘤糖酵解促进子宫内膜癌进展。
研究设计与样本
- 采用单细胞RNA测序和癌症基因组图谱(TCGA)数据检测子宫内膜癌中TRIB3表达。
- 使用免疫组化、qRT-PCR和western blot检测人子宫内膜癌与癌旁非肿瘤组织中TRIB3表达。
- 体外和体内验证TRIB3的致癌功能。
- 通过qRT-PCR、western blot、免疫共沉淀、双荧光素酶报告、免疫荧光双染、泛素化实验和染色质免疫沉淀研究TRIB3、E2F1与PKM2的相互作用。
主要发现
- TRIB3在子宫内膜癌组织中上调,其高表达与子宫内膜癌患者生存差相关。
- 功能获得和功能缺失分析显示TRIB3在子宫内膜癌中具有强促增殖、抗凋亡、促转移和促糖酵解能力。
- TRIB3可与E2F1相互作用抑制其降解,稳定表达的E2F1作为PKM2的转录因子增强其表达。
- 回补实验证实TRIB3通过稳定E2F1和增强PKM2转录促进子宫内膜癌细胞恶性行为和糖酵解。
- 异种移植小鼠模型中沉默TRIB3抑制子宫内膜癌生长和糖酵解;吲达帕胺被鉴定为TRIB3的化合物抑制剂,在体外抑制子宫内膜癌生长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Our purpose was to explore the effect and the potential mechanisms of tribbles pseudokinase 3 (TRIB3) on endometrial cancer (EC). METHODS: Single-cell RNA sequencing and the Cancer Genome Atlas (TCGA) data were used for detecting TRIB3 expression in EC. The expression of TRIB3 in human EC and para-carcinoma non-tumor tissues was examined using immunohistochemistry, qRT-PCR, and western blot. The oncogenic function of TRIB3 was verified both in vitro and in vivo. The interaction among TRIB3, E2F transcription factor 1 (E2F1) and pyruvate kinase M2 (PKM2) was studied via qRT-PCR, western blot, co-immunoprecipitation, dual luciferase reporter, immunofluorescence double staining, ubiquitination assay, and chromatin immunoprecipitation. RESULTS: TRIB3 was upregulated in EC tissues and its high expression was correlated with poor survival of patients with EC. Gain- and loss-of-function analyses showed that TRIB3 possessed strong pro-proliferative, anti-apoptotic, pro-metastatic, and pro-glucolytic capacities in EC. TRIB3 could interact with E2F1 to inhibit its degradation. The stablely expressed E2F1 acted as a transcription factor for PKM2 to enhance its expression. Rescue experiments confirmed that TRIB3 promoted EC cell malignant behavior and glycolysis via stabilizing E2F1 and enhancing PKM2 transcription. In xenograft mouse models, TRIB3 silencing inhibited EC growth and glycolysis. In addition, indapamide was identified as a compound inhibitor of TRIB3 to supress EC growth in vitro and in vitro. CONCLUSION: TRIB3 could promote the progression of EC through interacting with E2F1 and enhancing PKM2-mediated tumor glycolysis.
引用
- Geng F, Wang Y, Cui G, et al. TRIB3 promotes endometrial cancer progression through interacting with E2F1 and enhancing PKM2-mediated tumor glycolysis. Gynecol Oncol. 2025. PMID: 40997650. doi:10.1016/j.ygyno.2025.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。